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1.  INTRODUCTION 
 
 The reticuloendothelial system breaks down old red blood cells and bilirubin is one of 
the waste products that must be made water-soluble to be excreted. The unconjugated, 
bilirubin is carried by albumin to the liver, is in a lipid-soluble form, where it is 
conjugated by the enzyme uridine-diphosphate-glucuronosyltransferase 1A1 (UGT1A1) 
and excreted1. A polymorphisms in UGT1A1 gene, consisting in a TA duplication [(TA)7 
allele] in the repetitive TATA-box sequence of the gene promoter encoding this enzyme, 
result in a decreased capacity to glucuronidate bilirubin, a characteristic observed in 
Gilbert syndrome (GS)2. However, this polymorphism is not sufficient explain the inter-
individual variation and the presence of hiperbilirubinemia3. Recently, it was described 
that increased red cell mass probably plays a role in the pathogenesis of GS4. Since 
hemoglobin degradation is the principal determinant in bilirubin production, it may be 
possible that phenotypical differences between subjects related to red blood mass could 
explain some of the inter-individual variation.   
 The aim of this work is to investigate the putative role of increased red cell mass and the 
(TA)7 allele in bilirubin serum levels, in the Portuguese population.  
 4. DISCUSSION  
 
  Results obtained in this work showed that:  
   - among our population, 7 subjects were homozygous for the (TA)7 allele, 54 were heterozygous (TA)6 / (TA)7 and 48 were homozygous for the normal allele;  
   - comparing bilirubin serum levels (SBL) according to the UGT1A1 genotype, we found statistically differences in SBL between genotypes (p<0.001); 
   - a positive significant correlation was found between SBL and hematocrit (r=0,209; p=0,029 ) and between SBL and mean cell volume (r=0,206; p=0,032 );  
  - statistically differences in Red Blood Cell Count were found between hiperbilirubinemic and normobilirubinemic subjects (p=0,022) and a trend to higher          hematocrit 
was found in hiperbilirubinemic subjects (p=0,073).  
   
  Taken in account that some studies refer sub-clinical hemolisis and reduced life span of erythrocytes6 as important factors in hiperbilirubinemia  it is remarkable having 
red blood cell mass correlated positively  with serum bilirubin levels.  Further studies including a larger group of controls and GS patients [homozygous for the (TA)7 allele] are 
required to analyze the same parameters separated by gender since males have higher red cell blood mass and higher bilirubin tournover7. Dependence on red cell mass 
explains why this condition is more frequent in males4. 
   This data suggests that in our population the presence of abnormal number of TA repeats in the UGT1A1 gene is associated with increased bilirubin levels and that 
increased red blood mass could contribute for this phenotype.  
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2. MATERIAL AND METHODS  
 
Subjects and assays 
  This study was performed in 109 volunteer healthy young adults (20.3±1.9 years) without 
liver and/or hematological disorders. Blood samples were collected and processed in order to 
determine bilirubin serum levels, complete blood cells count, and DNA extraction. The TATA-box 
region was analyzed by PCR amplification followed by subsequent analysis by automated 
capillary electrophoresis as previously described5. 
 
 
Data Analysis 
  For statistical analysis, we used the Statistical Package for Social Sciences (SPSS; version 
16.0 for Windows, Inc. Chicago, IL, USA). Kolmogorov Smirnov statistics were used to evaluate 
sample normality distribution. Spearman´s rank correlation coefficient was used to evaluate 
relationships between sets of data. Total bilirubin values were categorized in normal and 
hiperbilirubinemic (>17,1µmol/L). The variable TA Repeat Polymorphism was categorize in 
normal (6/6), Heterozygous (6/7) and  Homozygous (7/7). Comparation between groups were 
performed using the Kruskal-Wallis test and the Mann-Whitney U test. Significance was 
accepted at p<0.05 
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Fig. 1. Correlations between serum bilirubin levels 
and: Mean Red Cell Volume (A) and  Hematocrit 
(B). Differences between normabilirubinemic and 
hiperbilirubinemic subjects: in TA Repeat 
Polymorphism (C). Hematocrit (D) and Red Blood 
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3. RESULTS 
